13th Annual Tumor Models

Topics

• Applications in drug discovery & screening
• Navigating next-generation oncology models: from modelling tumor microenvironment to interrogating moa
• Applications for efficacy evaluation & biomarker discovery
• Track moderator: hongyu xue, director, in vivo pharmacology, bayer
• Pitting in vitro vs in vivo modelling to investigate case studies in improving translatability
• Track moderator: regina reilly, research fellow, abbvie
• Leveraging omics technology & data to better characterize tumor microenvironment & cellular interactions
• From bench to bedside: leveraging tumor models to establish relevant biomarkers & using preclinical data to support an ind